Tuesday, 10 December 2019

India News

  • Sanofi, Carlyle to buy Elder Pharma for $450 mn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Sanofi's India unit and Carlyle group are in talks to buy the domestic drug formulation business of Indian drug major Elder Pharmaceuticals in a deal worth $400-to-450 million, a...Read more

  • India's Assam to launch miracle TB drug

    India |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2016

    Singapore: As per reports, the Indian state of Assam has become the first state in Asia to launch a new drug that can combat multi-drug resistant tuberculosis. The drug, Bedaquiline (BDQ) c...Read more

  • New genomes of malaria sequenced, vaccine to follow

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

    A group of scientists working in India and the US has sequenced and annotated the genomes of four Plasmodium vivax strains collected from disparate geographic locations in West Africa, Sout...Read more

  • Sri Lanka encourages Indian pharma companies to set up units in the country

    India |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jul, 2016

    Singapore: In a bid to strengthen the pharma relations between the two countries, Sri Lankan Trade minister has planned a visit India, to encourage Indian pharmaceutical companies to establ...Read more

  • Indian govt relaxes clinical trial norms

    India |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2016

    Singapore: In a bid to woo global researchers and improve the clinical trial landscape in the country, the Indian government has decided to relax rules and ease clinical trial procedures in...Read more

  • India, Australia partner to foster sugar research

    India |  News | By BioSpectrum Bureau  | 0 Comment | 04 May, 2016

    Singapore: Sugar Research Australia recently announced a new research partnership with India to further research and foster the development of new sugarcane varieties. The team aims to focu...Read more

  • German firm Evotec to pack up from India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Singapore: Custom manufacturing German firm, Evotec is closing its Chemistry Operations in Thane, India. All chemistry efforts will now be performed at its Abingdon (UK) facility to answer ...Read more

  • Lambda appointed new president

    India |  News | By BioSpectrum Bureau  | 0 Comment | 18 Apr, 2016

    Singapore: Lambda Therapeutic Research announces the joining of Dr Tausif Monif as President - Global Operations. Lambda is a leading Global CRO in the Clinical research domain headquarter...Read more

  • Asia's first dental stem cell bank is here

    India |  Influencers | By BioSpectrum Bureau  | 1 Comment | 28 Oct, 2013

    With the experience of scientists having discovered the optimum medical therapeutic utilizing the nucleus of regenerative medicine - stem cell therapy, founders of India and Asia's first de...Read more

  • GSK sells thrombosis brands to Aspen for $1.1 bn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: GlaxoSmithKline (GSK) has agreed to sell its thrombosis brands, Arixtra and Fraxiparine, and Notre-Dame de Bondeville (NDB) manufacturing site to South African pharmaceuticals co...Read more

  • Why are bio firms in a hurry to set up shop in Malaysia?

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2013

    India-based Agila Biotech, which is a subsidiary of Strides Arcolab, entered into a $34.4 million (RM107 million) build-and-lease agreement with Malaysian Bio-Xcell, to set up a customized ...Read more

  • India's Arunachal Pradesh to get Digital Healthcare Centers

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2016

    Singapore: India's northeastern state of Arunachal Pradesh is wooing Samsung Electronics to set up units in the state. The state Chief Minister Mr Pema Khandu recently met representatives o...Read more

  • Mylan holds back $250 mn in Agila buyout

    India |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2013

    Singapore: With the US drug regulator, Food and Drug Administration (FDA) issuing a warning letter to one of Agila's Specialties plant, Mylan has said that it is holding back $250 million o...Read more

  • Biobanking has attractive prospects in Asia

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2012

    Asia is becoming increasingly important as a market for upcoming biobanks. Within Asia, India, China and Japan have attractive prospects. Many countries in Asia have launched or are about t...Read more

  • China Cord Blood, Cordlife join hands for stem cell therapy services

    India |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2014

    Singapore: China Cord Blood Corporation (CCBC) and Cordlife Group, a multi-product healthcare company catering to the mother and child segment, have come together to assist patients across ...Read more

  • Johns Hopkins releases NCD policy briefs

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

    Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterprise has released a focused set of policy briefs that provide actionable...Read more

  • Lupin appoints Theresa Stevens as chief corporate development officer

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Pharma major Lupin announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations. Ms Stevens will assume full responsibility for g...Read more

  • Type 2 diabetes could be next epidemic in India, China

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 07 Feb, 2013

    Singapore: Despite modern science's best efforts, the most common type of diabetes, Type 2, is reaching epidemic levels across the world, especially India and China, according to market ana...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls